NEWSROOM

NASDAQ

SKYX Announces Issuance of 8 Additional New Patents in the U.S. and International including China, Europe and 2 Patents in India, for its Advanced, Smart Home and AI Platform Technologies

SKYX Announces Issuance of 8 Additional New Patents in the U.S. and International including China, Europe and 2 Patents in India, for its Advanced, Smart Home and AI Platform Technologies

SKYX Enhances its Robust Patent Portfolio Which Now Totals over 90 Issued and Pending Patents with over 30 Issued Patents SKYX’s Patents Enable and Enhance Performance of Smart Home and AI sensors in Addition to Home Safety Sensors MIAMI, FL, April 04, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 90 issued and pending patents in US and globally, and over 60 lighting and home décor websites, with a mission to make homes...

read more
Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors

Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors

Dr. Lawal has Deep Renewable Energy Expertise in Chemical Energy Conversion Processes MILTON, NY, April 03, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, announced the election of Dr. Adeniyi Lawal to the Company’s Board of Directors effective today. Dr. Lawal is expected to eventually replace Dr. Donald F. Mowbray, the Board member with the most significant technical expertise, who has indicated that he may not stand for...

read more
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

Pittsburgh, PA, April 03, 2024 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that the U.S. Food and Drug Administration (“FDA”) has granted a Type C meeting request to discuss the company’s proposed Phase-2b clinical trial design for the evaluation of LP-10, an intravesical liposomal formulation of tacrolimus, as a potential treatment for...

read more
AmpliTech Group’s Division AGTGSS, Riding The Crest Of Its Recent O-RAN CAT B 64T64R MIMO Radio Release, Teams Up With the Open6G OTIC at the Institute for the Wireless Internet of Things (WIoT) at Northeastern University To Perform O-RAN 5G Interoperability Testing

AmpliTech Group’s Division AGTGSS, Riding The Crest Of Its Recent O-RAN CAT B 64T64R MIMO Radio Release, Teams Up With the Open6G OTIC at the Institute for the Wireless Internet of Things (WIoT) at Northeastern University To Perform O-RAN 5G Interoperability Testing

HAUPPAUGE, NY, April 02, 2024 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, other communications networks, design of complete 5G/6G systems, global distributor of packages and lids for integrated circuit assembly, today announced teaming up with the Open6G Open Testing and Integration Center (OTIC) at the Institute for the Wireless Internet of Things (WIoT) at Northeastern University (NU)...

read more
Blackboxstocks Acquisition Target Evtec Reports Revenue Increased 115% in FY2023 Projects $52 Million for FY2024

Blackboxstocks Acquisition Target Evtec Reports Revenue Increased 115% in FY2023 Projects $52 Million for FY2024

Revenue Continues to Accelerate, Increasing 53% in First Half of FY2024 Dallas, TX, April 02, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today released financial results for the first half of FY2024 ended December 31, 2023, for its acquisition target company, Evtec Aluminum. https://prismmarketview.com/companies/blackbox/...

read more
BranchOut Food Announces 2023 Financial Results Ending Year at a $6.4M Run Rate with Current Commitments of $9.0M in Annualized Sales for 2024

BranchOut Food Announces 2023 Financial Results Ending Year at a $6.4M Run Rate with Current Commitments of $9.0M in Annualized Sales for 2024

2023 net revenue of $2.83M, up 276% versus prioryear due to major retailer engagements      BEND, Ore., April 02, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced its recent accomplishments and financial results for the fourth quarter and year ended December 31, 2023. Eric Healy, CEO of BranchOut Foods, said, “We are very pleased with BranchOut Food’s significant...

read more
Blackboxstocks Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2023

Blackboxstocks Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2023

Acquisition of Evtec Progressing Toward Closing Dallas, TX, April 01, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced the Company’s financial results for the fourth quarter and year ended December 31, 2023. https://prismmarketview.com/companies/blackbox/ Fourth Quarter and Annual Financial and Operating...

read more
SKYX Announces Issuance of 8 Additional New Patents in the U.S. and International including China, Europe and 2 Patents in India, for its Advanced, Smart Home and AI Platform Technologies

SKYX Reports Record  Sales of $58.8 Million for 2023 and Fourth Quarter Record Sales of $22.2 Million as it Continues to Enhance its Market Penetration for Both Retail and Pro Segments

 SKYX reports $22.4 million in cash, cash equivalents, restricted cash, available cash, and investments available for sale as of December 31, 2023, as compared to $16.8 million as of December 31, 2022 MIAMI, FL, April 01, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with 77 pending and issued patents IN THE US and globally and over 60 lighting and home décor websites, with a mission to make...

read more
AmpliTech Group’s Division AGTGSS, Riding The Crest Of Its Recent O-RAN CAT B 64T64R MIMO Radio Release, Teams Up With the Open6G OTIC at the Institute for the Wireless Internet of Things (WIoT) at Northeastern University To Perform O-RAN 5G Interoperability Testing

AmpliTech Reports FY 2023 Results; Core Business Sales Increased YoY, 5G ORAN Radio Products And Over 100 New SKU’s Released During FY2023, All Available For Sale Now

Gross Margin Expands to nearly 47% in FY2023 In Comparison to FY2022 Gross Margin of 46.0% HAUPPAUGE, NY, April 01, 2024 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, today announced financial results for year ended December 31,...

read more
AmpliTech Group’s Division AGTGSS, Riding The Crest Of Its Recent O-RAN CAT B 64T64R MIMO Radio Release, Teams Up With the Open6G OTIC at the Institute for the Wireless Internet of Things (WIoT) at Northeastern University To Perform O-RAN 5G Interoperability Testing

AmpliTech Group Showcases Remarkable Success At The Satellite Show In Washington DC Held March 19 to March 21, 2024

HAUPPAUGE, NY, April 01, 2024 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, today announced its exceptional achievements at the recently concluded Satellite Show held in Washington D.C. The event proved to be an extraordinary...

read more
SKYX Announces Issuance of 8 Additional New Patents in the U.S. and International including China, Europe and 2 Patents in India, for its Advanced, Smart Home and AI Platform Technologies

SKYX Announces Corporate Update Call

Company to Present Fourth Quarter and 2023 Full Year Financial Results; Conference Call on April 1st, 4:30 PM EST MIAMI, FL, March 27, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 77 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that it will host a Corporate Update...

read more
Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors

Sono-Tek to Present at The LD Micro Invitational XIV

Presentation on Tuesday, April 9, 2024, at 8:30 am ET MILTON, NY, March 27, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it will be presenting at the 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024. The event is expected to feature 80 companies presenting in half-hour increments, as well as private 1:1 meetings.  Sono-Tek is scheduled to present on Tuesday, April 9,...

read more
PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

New York, N.Y., March 25, 2024 - PRISM MarketView - Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease areas. It takes 12 years on average for a company to take a drug from discovery to commercialization, and every hard-won FDA approval is a cause for celebration for researchers, companies and the end-users whose lives may be changed by these treatments. The past few...

read more
PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

New York, N.Y., March 18, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights the FDA’s landmark approval of Rezdiffra™ and the companies leading the charge in developing new, safe, and effective treatments for liver disease. The landmark decision has shone a light on metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic fatty liver disease, a leading cause of liver-related mortality that affects between...

read more
SKYX Announces Issuance of 8 Additional New Patents in the U.S. and International including China, Europe and 2 Patents in India, for its Advanced, Smart Home and AI Platform Technologies

SKYX to Participate in the 36th Annual ROTH Conference

MIAMI, FL, March 18, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 77 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that management will participate in the 36th Annual ROTH Conference, which is being held March 17-19, 2024 in Dana Point, California. Founder and...

read more
BranchOut Food Announces 2023 Financial Results Ending Year at a $6.4M Run Rate with Current Commitments of $9.0M in Annualized Sales for 2024

BranchOut Food to Debut New Products at Natural Products Expo West

Natural Products Expo West showcases trending products for retailers stocking stores shelves nationwide BranchOut Food will launch two new products lines including Salad Toppers and Kids’ Snack Packs BEND, Ore., March 13, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that it will debut a brand refresh and launch two new product lines at its exhibit at the Natural Products Expo West,...

read more
PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

New York, N.Y., March 07, 2024 - PRISM MarketView announces the release of an insightful interview with Lipella Pharmaceuticals’ CEO, Dr. Jonathan Kaufman, discussing the company's recent regulatory accomplishments and how investors stand to benefit. Lipella Pharmaceuticals was recently granted Orphan Drug Designation by the FDA for LP-410, its drug candidate for oral Graft-versus-Host Disease (GvHD) and previously received Orphan Drug Designation for LP-10 in 2023. With these nods from the...

read more
SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

New York, March 06, 2024 - PRISM MediaWire - SKYX Platforms Corp. (Nasdaq: SKYX) announces a strategic partnership with Golden Lighting, a renowned manufacturer and premier provider of elegant lighting solutions. This collaboration aims to facilitate SKYX's introduction of innovative smart and advanced plug & play products to a broader spectrum of online, builder, and professional clientele. https://prismmarketview.com/companies/skyx-platforms-corp/ Rani Kohen, Founder and Executive...

read more
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline

Clinical testing of LP-410 expected to commence in Q2 2024 Pittsburgh, PA, March 05, 2024 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for clinical testing of LP-410 in the treatment of oral Graft-Versus-Host Disease (GVHD). Lipella’s...

read more
Desalination Projects on Construction and Modernization in Latin America

Desalination Projects on Construction and Modernization in Latin America

New York City, February 28, 2024 Get for free the full list of desalination projects on construction and modernization in Latin America We are delighted to inform that Vostock Capital team has prepared a report called Desalination projects Latin America. The report includes all Latin America projects for desalination plants.  The report was prepared prior to the 6th International Conference and Exhibition Desalination Latin America (13-14 March, 2024 –...

read more
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day

PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day

New York, N.Y., February 29, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, recognizes the remarkable contributions of companies developing treatments for the 10,000 rare diseases affecting more than 30 million Americans. All areas of medicine, and all organs and body systems, are impacted by rare diseases, including rare neurological and neuromuscular diseases, metabolic, skin and bone diseases, and chromosomal disorders. Approximately 95% of rare...

read more
Desalination Projects on Construction and Modernization in Latin America

Discover the latest innovations at the Desalination Latin America 2024 Congress

New York City, February 28, 2024 Discover the latest innovations at the Desalination Latin America 2024 Congress Registration is now open Date: 13-14 March 2024Location: Santiago, ChileOfficial WebsiteOrganizer: Vostock Capital The 6th Conference and exhibition “Desalination Latin America 2024” focuses on the latest achievements in desalination industry in Latin America. The event is dedicated to building business connections, showcasing the new desalination projects and innovations and...

read more
PRISM MarketView Launches Emerging Consumer Products Index

PRISM MarketView Launches Emerging Consumer Products Index

Emerging companies harness advanced tech to innovate, launch new products, and adapt to inflation in consumer markets New York, N.Y., February 27, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging Consumer Products Index. As technologies advance, new innovative products are continuously being developed by emerging companies. These companies play a pivotal role in driving market dynamics and...

read more
Utilizing RSS News Feeds as an Alternative Method for Stock News Updates – by PRISM MediaWire

Utilizing RSS News Feeds as an Alternative Method for Stock News Updates – by PRISM MediaWire

New York City, February 26, 2024 – In an age where access to information is paramount, navigating the labyrinth of subscription-based news services can often feel daunting and financially burdensome. RSS (Rich Site Summary or Really Simple Syndication) feeds have long been celebrated for aggregating content from multiple sources into a single, easily digestible format. Users can tailor their news feeds according to their interests and preferences, selecting specific topics, keywords, or...

read more
BranchOut Food Announces 2023 Financial Results Ending Year at a $6.4M Run Rate with Current Commitments of $9.0M in Annualized Sales for 2024

BranchOut Food Significantly Expands Relationship with Nation’s Largest Warehouse Club with New Orders Adding ~$900,000 in Q3 of 2024

After exceptional sales in the California regions, BranchOut expands into 7 more states Several additional regions now reviewing BranchOut Food’s products due to exceptional sales BEND, Ore., February 26, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that it has broadened its existing relationship with the nation’s largest warehouse club following exceptional sales of its popular...

read more
BLACKBOXSTOCKS, INC. ACQUISITION TARGET, EVTEC ALUMINIUM, APPOINTS THREE NEW BOARD MEMBERS

BLACKBOXSTOCKS, INC. ACQUISITION TARGET, EVTEC ALUMINIUM, APPOINTS THREE NEW BOARD MEMBERS

Evtec Aluminium strengthens its Board of Directors with the appointment of Julia Steinbrenner, Steve Norris and Steve Illot Dallas, TX, February 20, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, announced today that its planned acquisition target, Evtec Aluminium Limited (“Evtec”), has appointed three new Board Members....

read more
Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference

Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference

Chief Medical Officer Dr. Michael Chancellor will discuss hemorrhagic cystitis and the company’s lead candidate, LP-10 Pittsburgh, PA, February 20, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company") a pioneering, clinical-stage pharmaceutical company, announced today that Chief Medical Officer Dr. Michael Chancellor will present at the PropThink Digital Investor Conference’s key opinion leader (KOL) discussion on Friday, February 23, 2024, at 2 PM ET....

read more
BranchOut Food Announces 2023 Financial Results Ending Year at a $6.4M Run Rate with Current Commitments of $9.0M in Annualized Sales for 2024

BranchOut Food Expands Relationship with Nation’s Largest Retailer, Valued at an estimated $7.6M Annually

BEND, Ore., February 12, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that it has expanded its relationship with the nation’s largest retailer. The new agreement is valued at an estimated $7.6 million annually. BranchOut has renewed its contract with the retailer for two products and entered into a new contract for two additional products. The company received a 12-month contract...

read more
PRISM MarketView Highlights BranchOut Food as Company Reaches Revenue Records

PRISM MarketView Highlights BranchOut Food as Company Reaches Revenue Records

New York, N.Y. February 8, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights BranchOut Food (NASDAQ: BOF), a pioneering food technology company with a smart growth strategy that is helping it achieve new revenue records each quarter. BranchOut Food Inc. is a snack food company with a difference. The company produces dehydrated fruit and vegetable-based products using a disruptive technology known as GentleDry, that enables the company to...

read more
PRISM CEO CORNER – Eric Healy, BranchOut Food – Reaching Record Revenues with Disruptive Food Technology

PRISM CEO CORNER – Eric Healy, BranchOut Food – Reaching Record Revenues with Disruptive Food Technology

New York, February 7, 2024 - Consumer demand for healthier and more sustainable food options is on the rise in the US. According to the World Economic Forum, around 50% of Americans say they are actively trying to make healthy eating choices, but a culture of snacking may be getting in the way of the best intentions. This year alone, the US snack food market is valued at more than $108 billion. BranchOut Food Inc. (NASDAQ: BOF), is a snack food company with a difference. Its fruit and...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850